Diazoxide Choline Controlled-Release Tablet (DCCR) for Very High Triglycerides

首次发布于 2009 年 9 月 9 日

A 5 Treatment Period Pharmacokinetic Study Evaluating Dose Proportionality and Food Effects of Diazoxide Choline Controlled-Release Tablet (DCCR)

计划入组 32 人 · 首次发布于 2016 年 9 月 8 日

Clinical Study of Diazoxide Choline Controlled-Release Tablet (DCCR) in Patients With Prader-Willi Syndrome

计划入组 13 人 · 首次发布于 2014 年 1 月 13 日

Diazoxide(Proglycem)

C₈H₇ClN₂O₂S · Rx

Lacosamide controlled release

Hydromorphone controlled release

CONTROLLED MEDICATIONS LIMITED

Hong Kong, China

FERRING CONTROLLED THERAPEUTICS LIMITED

United Kingdom

Ferring Controlled Therapeutics Ltd.

United Kingdom

Soleno Therapeutics Gains FDA Support for DCCR Trial Design in Prader-Willi Syndrome

FDA Grants Priority Review to Soleno's DCCR for Prader-Willi Syndrome

Soleno Therapeutics' DCCR for Prader-Willi Syndrome Receives Priority Review from FDA